Zimbabwe Pharmaceuticals and Healthcare Report Q1 2016

Date: December 30, 2015
Pages: 66
US$ 1,295.00
Report type: Strategic Report
Delivery: Download

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Although the government's ambition to develop a national health insurance scheme to facilitate universal health coverage is a positive step, Zimbabwe's healthcare system, in its current state, is heavily dependent on donor funds, owing to past failures to sufficiently finance its health sector. Global recession is presenting a significant risk as the availability of funds from foreign organisations dries up. Political instability and a grim economic outlook enforce our view that Zimbabwe will remain an unattractive market for multinational drugmakers.

Headline Expenditure Projections

Pharmaceuticals: USD361mn in 2014 to USD380mn in 2015; +5.2% in US dollar terms. Forecast unchanged from last quarter.
BMI Industry View
    Table: Headline Pharmaceuticals & Healthcare Forecasts (Zimbabwe 2013-2019)
Industry Forecast
Pharmaceutical Market Forecast
    Table: Pharmaceutical Sales, Historical Data And Forecasts (Zimbabwe 2011-2019)
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
Pharmaceutical Trade Forecast
    Table: Pharmaceutical Trade Data And Forecasts (Zimbabwe 2013-2019)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q1 2016
Zimbabwe Risk/Reward Index
Regulatory Review
Regulatory Regime
Intellectual Property Developments
Counterfeit Drugs
Pricing And Reimbursement Regimes
Public Drug Procurement
Market Overview
Healthcare Sector
    Table: Zimbabwe: Healthcare Facilities
Healthcare Funding
Health Insurance
Healthcare Staff
Traditional Medicine
Clinical Trials
Competitive Landscape
Pharmaceutical Industry
Domestic Industry
Foreign Industry
Pharmaceutical Sector Developments
Retail Pharmacy Sector
Company Profile
Varichem Laboratories
Demographic Forecast
    Table: Population Headline Indicators (Zimbabwe 1990-2025)
    Table: Key Population Ratios (Zimbabwe 1990-2025)
    Table: Urban/Rural Population & Life Expectancy (Zimbabwe 1990-2025)
    Table: Population By Age Group (Zimbabwe 1990-2025)
    Table: Population By Age Group % (Zimbabwe 1990-2025)
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
    Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2015 US$ 1,295.00 Sep, 2015 · 82 pages

Ask Your Question

Zimbabwe Pharmaceuticals and Healthcare Report Q1 2016
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: